Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Emotional and physical distress of medication errors reported to a German poison information centre: a prospective follow-up study among patients and caregivers.

Clinical toxicology (Philadelphia, Pa.)·2026
Same author

Network-driven discovery yields new insight into Shox2-dependent cardiac rhythm control.

Biochimica et biophysica acta. Gene regulatory mechanisms·2021
Same author

Corrigendum to 'Management of Chronic Venous Disease: Clinical Practice Guidelines' [European Journal of Vascular & Endovascular Surgery 49/6 (2015) 678/737].

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2019
Same author

A zebrafish model for FHL1-opathy reveals loss-of-function effects of human FHL1 mutations.

Neuromuscular disorders : NMD·2018
Same author

Comparison of video analysis and simulations of a drum coating process.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2017
Same author

Applicability of contrast-enhanced ultrasound in the diagnosis of plantar fasciitis.

Scandinavian journal of medicine & science in sports·2017
Same journal

Evaluation of generative artificial intelligence in producing anatomically distinct lipedema subtypes: A diagnostic accuracy study.

Phlebology·2026
Same journal

Obituary for professor Eberhard Rabe.

Phlebology·2026
Same journal

Endovenous vacuum-assisted laser ablation (VALA) for the treatment of great saphenous vein aneurysm close to the junction (Type I).

Phlebology·2026
Same journal

Response to the letter to the editor: "Methodological considerations in the evaluation of pain and central sensitization in lipedema".

Phlebology·2026
Same journal

Women's awareness and knowledge of lipedema in Turkey: Findings from a nationwide online survey.

Phlebology·2026
Same journal

Prevalence of saphenofemoral junction reflux and lower-limb venous diameters in kidney transplant recipients: A cross-sectional duplex ultrasound study.

Phlebology·2026
See all related articles

Related Experiment Video

Updated: May 13, 2026

Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

Indications for stenting during thrombolysis.

N Bækgaard1, R Broholm, S Just

  • 1Vascular Clinic, Gentofte Hospital and Rigshospitalet, Niels Andersensvej 65, DK-2900 Hellerup, Copenhagen, Denmark. baekgaard@dadlnet.dk

Phlebology
|March 14, 2013
PubMed
Summary
This summary is machine-generated.

For deep venous thrombosis (DVT) affecting the iliofemoral veins, stenting is crucial for restoring blood flow. This intervention addresses persistent blockages after thrombolysis, improving outcomes in iliofemoral DVT treatment.

More Related Videos

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo
06:38

The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo

Published on: December 19, 2025

Related Experiment Videos

Last Updated: May 13, 2026

Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo
06:38

The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo

Published on: December 19, 2025

Area of Science:

  • Vascular Surgery
  • Interventional Radiology
  • Cardiovascular Medicine

Background:

  • Deep venous thrombosis (DVT) in the iliofemoral vein segment has poor spontaneous recanalization rates, especially on the left side.
  • Iliac vein compression syndrome, caused by external pressure, exacerbates iliofemoral DVT, particularly in left-sided cases.
  • Persistent obstructive lesions after catheter-directed thrombolysis necessitate supplementary endovenous procedures.

Purpose of the Study:

  • To highlight the importance of endovenous stenting in managing iliofemoral deep venous thrombosis (DVT) with persistent obstructive lesions.
  • To emphasize stenting as the preferred treatment for restoring venous outflow in the iliofemoral segment post-thrombolysis.
  • To discuss the anatomical challenges and stent characteristics required for successful iliofemoral venous stenting.

Main Methods:

  • Review of endovenous procedures for iliofemoral DVT management.
  • Analysis of the role of catheter-directed thrombolysis and subsequent interventions.
  • Evaluation of stent characteristics (self-expandable, flexible, radial force) for iliofemoral venous stenting.

Main Results:

  • Stenting is the treatment of choice for persistent iliofemoral venous obstructions post-thrombolysis.
  • Self-expandable, flexible stents with adequate radial force are necessary to overcome anatomical challenges like external compression and curved segments.
  • Balloon angioplasty alone is insufficient for treating these complex venous lesions.

Conclusions:

  • Endovenous stenting is essential for achieving unobstructed venous outflow in the iliofemoral segment after thrombolysis for DVT.
  • The unique anatomical features of the iliofemoral veins, including external compression, necessitate specific stent properties for effective treatment.
  • Supplementary stenting procedures are critical for improving outcomes in patients with iliofemoral DVT and persistent obstructive lesions.